Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:NuVasive
|
| gptkbp:CEO |
Dan Scavilla
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:foundedYear |
2003
|
| gptkbp:founder |
gptkb:David_Paul
|
| gptkbp:headquartersLocation |
Audubon, Pennsylvania, United States
|
| gptkbp:industry |
Medical devices
|
| gptkbp:numberOfEmployees |
~3000
|
| gptkbp:products |
Orthopedic devices
Robotic surgery systems Spinal implants |
| gptkbp:publiclyTraded |
true
|
| gptkbp:revenue |
$1.02 billion (2022)
|
| gptkbp:specialty |
Spine surgery
Musculoskeletal solutions Orthopedic trauma |
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
GMED
|
| gptkbp:website |
https://www.globusmedical.com/
|
| gptkbp:bfsParent |
gptkb:NuVasive
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Globus Medical
|